研究关注:First measles treatment advances as vaccination rates drop
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by ...
## 事件概览
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by ...
## 核心信息
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry into the cell. This is the first time that antibodies have been shown to bind effectively to two essential viral proteins, creating a dual blockade that prevents infection. Unlike the current vaccine, which is based on an attenuated virus and is not recommended for immunocompromised individuals, these monoclonal antibodies could be used both as a new vaccine approach and as a treatment for the entire population.
## 为什么值得关注
这条内容与 cell biology 相关,可能影响科研选题、技术趋势判断或产业观察。BioDir 已根据来源、摘要长度、主题词和潜在影响给出 51 分的候选评分。
## 发布提示
发布前应核对原文链接、研究对象、样本规模、方法限制和结论边界。若来源为 bioRxiv 或 medRxiv,应明确标注其为预印本,尚未经过同行评议。